Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
ERJ Open Research
|
November 16, 2022
Dual CFTR modulator therapy efficacy in the real world: lessons for the future
Anna-Maria Dittrich, Sandra Y Chuang
Klinische Padiatrie
|
December 10, 2024
CFTR Modulator Treatment in Children<12 Years of Age - Status Quo and Challenges
Dominik Funken, Katharina Schütz, Anna-Maria Dittrich
Medizinische Klinik (Munich, Germany : 1983)
|
September 17, 2002
[Hypo-osmolar hyponatremia as the chief symptom in hypothyroidism]
Roland Schmitt, Anna Maria Dittrich, David Groneberg, et al.
ERJ Open Research
|
August 5, 2025
Cystic fibrosis transmembrane conductance regulator therapy with elexacaftor/tezacaftor/ivacaftor reduces detection of hallmark cystic fibrosis pathogens in Europe: progress made but no time to slow down
Katharina Schütz, Sophia T Pallenberg, Ilona Rosenboom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 30, 2023
Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis
Anna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, et al.
NPJ Biofilms and Microbiomes
|
December 15, 2020
The human respiratory tract microbial community structures in healthy and cystic fibrosis infants
Marie-Madlen Pust, Lutz Wiehlmann, Colin Davenport, et al.
Plos One
|
October 3, 2012
IL-4 attenuates pulmonary epithelial cell-mediated suppression of T cell priming
Melanie Albrecht, Markus Arnhold, Sandra Lingner, et al.
Scientific Reports
|
November 12, 2017
Suppression of Th17-polarized airway inflammation by rapamycin
Oana Joean, Anja Hueber, Felix Feller, et al.
Experimental Lung Research
|
May 6, 2009
Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease
Birgit Ahrens, Tobias Freund, Ro-Dug Rha, et al.
Microbiology Spectrum
|
September 26, 2022
Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome
Sophia T Pallenberg, Marie-Madlen Pust, Ilona Rosenboom, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
ERJ Open Research
|
November 16, 2022
Dual CFTR modulator therapy efficacy in the real world: lessons for the future
Anna-Maria Dittrich, Sandra Y Chuang
Klinische Padiatrie
|
December 10, 2024
CFTR Modulator Treatment in Children<12 Years of Age - Status Quo and Challenges
Dominik Funken, Katharina Schütz, Anna-Maria Dittrich
Medizinische Klinik (Munich, Germany : 1983)
|
September 17, 2002
[Hypo-osmolar hyponatremia as the chief symptom in hypothyroidism]
Roland Schmitt, Anna Maria Dittrich, David Groneberg, et al.
ERJ Open Research
|
August 5, 2025
Cystic fibrosis transmembrane conductance regulator therapy with elexacaftor/tezacaftor/ivacaftor reduces detection of hallmark cystic fibrosis pathogens in Europe: progress made but no time to slow down
Katharina Schütz, Sophia T Pallenberg, Ilona Rosenboom, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 30, 2023
Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis
Anna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, et al.
NPJ Biofilms and Microbiomes
|
December 15, 2020
The human respiratory tract microbial community structures in healthy and cystic fibrosis infants
Marie-Madlen Pust, Lutz Wiehlmann, Colin Davenport, et al.
Plos One
|
October 3, 2012
IL-4 attenuates pulmonary epithelial cell-mediated suppression of T cell priming
Melanie Albrecht, Markus Arnhold, Sandra Lingner, et al.
Scientific Reports
|
November 12, 2017
Suppression of Th17-polarized airway inflammation by rapamycin
Oana Joean, Anja Hueber, Felix Feller, et al.
Experimental Lung Research
|
May 6, 2009
Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease
Birgit Ahrens, Tobias Freund, Ro-Dug Rha, et al.
Microbiology Spectrum
|
September 26, 2022
Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome
Sophia T Pallenberg, Marie-Madlen Pust, Ilona Rosenboom, et al.
Page
of 8